| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8956127 | EBioMedicine | 2018 | 15 Pages |
Abstract
LncRNA MEG3 and its target miR-147 may serve as a novel therapeutic target for CML blast crisis, and chidamide might have a potential clinical application in treating CML blast crisis.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Zi-ye Li, Lin Yang, Xiao-jun Liu, Xing-zhe Wang, Yu-xia Pan, Jian-min Luo,